Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetylcholinesterase inhibition and orthostatic hypotension in Parkinson's disease
2012-000122-21Phase 2Terminated
- Sponsor
- Department of Neurology, Zealand University Hospital
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of pyridostigmine in orthostatic hypotension (OH) and Parkinson's disease (PD), sponsored by Department of Neurology, Zealand University Hospital. Primary endpoints: Change in systolic blood pressure with head-up tilt and Change in diastolic blood pressure with head-up tilt. Started Jun 2012; status: terminated.
02
Drugs
pyridostigmine
03
Conditions
orthostatic hypotension (OH)Parkinson's disease (PD)
Beyond the preview
Go deeper on 2012-000122-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000122-21.